Compare
TracePharma as an LSPedia OneScan alternative
LSPedia is a mature, full-stack global traceability platform. TracePharma is a focused L4 DSCSA hub for US supply-chain participants who need operator UX, direct partner connectivity, and SaaS time-to-value—not global regulation modules they will not use.
Teams evaluate LSPedia when they need a proven DSCSA suite with broad module coverage and network-scale partner exchange. Teams look at TracePharma when they want the same EPCIS-native L4 core—receive, ship, exceptions, compliance.
TracePharma fits when you do not want to fund global hubs, financial rev-cycle modules, or consultant-heavy configuration your team will not operate.
This page is intentionally honest. LSPedia wins on global regulation breadth and Exchange scale. TracePharma wins on operator UX, EPCIS 2.0 depth, profile-tuned SaaS, and lower TCO for SMB–mid-market manufacturers, wholesalers, 3PLs, and dispensers.
Feature comparison
Core US DSCSA workflows overlap on both platforms. LSPedia's global module catalog and Exchange network are where breadth diverges.
| Capability | LSPedia OneScan | TracePharma |
|---|---|---|
| EPCIS ingest & outbound | Strong — full serialization suite | Strong — unified L4 workspace |
| EPCIS 2.0 repository | Yes | Yes — CBV 2.0 capture, queries, subscriptions |
| VRS verification | Yes — Pharmacy Pro SKU | Yes — profile-gated dispenser/distributor |
| Exception investigation | Investigator module | Structured exceptions + supplier correction loop |
| Partner connectivity | Exchange network (LSPedia publishes large connection counts) | Direct AS2, SFTP, HTTPS per tenant |
| L3 serial provisioning | Via partners / modules | Built-in SGTIN allocation + commissioning reconcile |
| 3PL principal ops | Edge / enterprise logistics | Principal-scoped receive, cross-dock, lot-level ship |
| Global regulation (EU FMD, L5 hubs) | Core strength | US DSCSA only — deliberate scope |
| Enterprise analytics (OneData/Vault) | Dedicated data platform | Scorecards + compliance export API |
| Implementation model | Often consultant-configured | Self-serve cutover + persona UX |
| Typical buyer | Enterprise + pharmacy chains | SMB–mid-market US trading partners |
Choose LSPedia when
- → You need EU FMD, country hubs, or multi-market regulation in one vendor—so you avoid stitching regional hubs and corporate reporting separately
- → Exchange network onboarding at scale is worth network fees—so unknown partners connect without manual credential projects per site
- → You want OneData/Vault-style enterprise analytics and data products—so compliance and finance share one governed dataset
- → Pharmacy chain deployments need Pharmacy Pro depth across hundreds of sites—so rollout stays on one vendor playbook
Choose TracePharma when
- → US DSCSA is your primary regulatory frame—so you do not pay for global modules your team never turns on
- → You connect known partners directly—so EPCIS routes to your tenant without mandatory exchange middleman fees
- → Floor staff need scan-first receiving and ship workflows—so receiving clerks finish receipts without consultant-only dashboards
- → You want profile-tuned tenancy (manufacturer, wholesaler, 3PL, dispenser) in one SaaS product—so one org can grow roles without new SKUs
By operating profile
Drug manufacturer
LSPedia competes on full global MAH programs. TracePharma fits US outbound EPCIS, L3 handoff, and customer ACK health without TraceLink-scale network fees.
Manufacturer solution →Drug wholesaler
LSPedia offers full DSCSA suite breadth. TracePharma emphasizes receive-to-ship operator UX, EPCIS 2.0 depth, and ACK monitoring at lower TCO.
Wholesaler solution →3PL / logistics
LSPedia Edge targets enterprise principal management. TracePharma delivers principal isolation, cross-dock audit, and lot-level ship for mid-market 3PLs.
3PL solution →Pharmacy / dispenser
LSPedia Pharmacy Pro and network visibility serve chains well. TracePharma fits independents needing wholesaler-grade EPCIS depth and PMS dispense-check APIs.
Pharmacy solution →Where TracePharma fits
Your plant runs L3 line software. TracePharma is the L4 corporate hub—EPCIS, partners, and compliance. National hubs (L5) stay outside our product; we connect your trading partners.
-
L3
Plant serialization
Line controllers, commissioning — software you already run
-
L4
TracePharma
EPCIS repository, partner connectivity, exceptions, compliance workflows
-
L5
National / regulatory hubs
FDA, EMVO, country hubs — not TracePharma; partners may connect upstream
TracePharma operates at L4—your corporate EPCIS hub. We integrate with L3 plant systems and connect to trading partners; we do not operate national regulatory hubs (L5) or EU FMD country gateways.
Evaluating a switch from LSPedia or a parallel pilot?
Share your operating profile, partner list, and must-have modules. Request a demo—we'll map an honest fit assessment and walk the workflows that matter.
LSPedia vs TracePharma FAQ
- Is TracePharma a full replacement for LSPedia OneScan?
- For US DSCSA L4 workflows—EPCIS ingest, outbound, exceptions, VRS, and compliance—TracePharma covers the core overlap. LSPedia remains stronger for global regulation modules, Exchange network scale, and enterprise analytics products like OneData.
- Who should choose TracePharma over LSPedia?
- SMB–mid-market US trading partners who want operator-first receiving and ship workflows, direct partner connectivity without exchange fees, and profile-tuned SaaS—not fifteen global regulation modules they will not use.
- Does TracePharma support EPCIS 2.0 like LSPedia?
- Yes. TracePharma ships a full EPCIS 2.0 repository with CBV 2.0 capture, queries, subscriptions, and OpenAPI—competitive with LSPedia serialization depth for US DSCSA programs.
Evaluating DSCSA providers? Download our checklist of questions to ask before you sign.